Back to search

Article

Sixteen-year longitudinal evaluation of blood-based DNA methylation biomarkers for early prediction of Alzheimer’s disease

2023-07-10

Abstract excerpt

<title>Abstract</title> <p> <italic> <bold>Background</bold> </italic> <bold>:</bold> DNA methylation (DNAm), an epigenetic mark reflecting both inherited and environmental influences, has shown promise for Alzheimer’s disease (AD) prediction. <italic> <bold>Objective</bold> </italic> : Testing long-term predictive ability (>15 years) of existing DNAm-based epigenetic age acceleration (EAA) measures and...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
4b2e369d-2f33-5d29-b697-e96b033b224c
DOI
10.21203/rs.3.rs-2276882/v4
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Sixteen-year longitudinal evaluation of blood-based DNA methylation biomarkers for early prediction of Alzheimer’s diseaseDOI 10.21203/rs.3.rs-2276882/v4
DNA methylation age from peripheral blood predicts progression to Alzheimer’s disease, white matter disease burden, and cortical atrophySemantic proximity
DNA methylation age from peripheral blood predicts progression to Alzheimer’s disease, white matter disease burden, and cortical atrophySemantic proximity
From aging to Alzheimer’s disease: concordant brain DNA methylation changes in late lifeSemantic proximity
A comprehensive study on epigenetic biomarkers in early detection and prognosis of Alzheimer's diseaseSemantic proximity
The Aging Epigenome: Integrative Analyses Reveal Functional Overlap with Alzheimer’s DiseaseSemantic proximity
Exploring novel blood-based DNA methylation biomarkers for alzheimer's disease via targeted sequencing of highly variable CpG sites.Semantic proximity
Distinct CSF biomarker-associated DNA methylation in Alzheimer's disease and cognitively normal subjectsSemantic proximity
Distinct CSF biomarker-associated DNA methylation in Alzheimer’s disease and cognitively normal subjectsSemantic proximity
Harnessing peripheral DNA methylation differences in the Alzheimer's Disease Neuroimaging Initiative (ADNI) to reveal novel biomarkers of disease.Semantic proximity
Epigenetic Peripheral Biomarkers for Early Diagnosis of Alzheimer’s DiseaseSemantic proximity
Whole genome methylation sequencing in blood identifies extensive differential DNA methylation in late‐onset dementia due to Alzheimer's diseaseSemantic proximity
Longitudinal data in peripheral blood confirm that PM20D1 is a quantitative trait locus (QTL) for Alzheimer’s disease and implicate its dynamic role in disease progressionSemantic proximity
Select a neighboring publication to make it the new centre.